ライフサイエンスコーパス: stop smoking

1 to reduce risk of weight gain in persons who stop smoking.

2 it attempts in individuals who are trying to stop smoking.

3 should be encouraged and better supported to stop smoking.

4 binoid receptor antagonists to help patients stop smoking.

5 tobacco on a daily basis and were willing to stop smoking.

6 ty of lung cancer patients were motivated to stop smoking.

7 aken for 1 week before patients attempted to stop smoking.

8 ved adequate training to help their patients stop smoking.

9 nd the antidepressant bupropion helps people stop smoking.

10 us revascularization should be encouraged to stop smoking.

11 ealth message for smokers continues to be to stop smoking.

12 ents are available in England to help people stop smoking.

13 cial incentives to support pregnant women to stop smoking.

14 ograms to help patients with type 2 diabetes stop smoking.

15 responded to the 8-year resurvey had by then stopped smoking.

16 5 years were categorised by the age they had stopped smoking.

17 at can cause craving years after someone has stopped smoking.

18 ly gain up to a decade of life expectancy by stopping smoking.

19 prior to time of diagnosis), recently quit (stopped smoking 2 months prior to time of diagnosis), an

20 -pyridyl)-1-butanone (NNK) in people who had stopped smoking: 4-(methylnitrosamino)-1-(3-pyridyl)-1-b

21 If all current smokers stopped smoking, 42% (95% CI, 21%-57%) and 21% (95% CI,

22 observations may help encourage patients to stop smoking after AMI.

23 ng before infarction), quitters (persons who stopped smoking after infarction), and active smokers (p

24 the procedure, n=2259), quitters (those who stopped smoking after the procedure, n=435), and persist

25 ensive intervention to encourage patients to stop smoking and avoid SHS.

26 ing norms are more likely to be motivated to stop smoking and to make a quit attempt.

27 as quantified in the urine of people who had stopped smoking and used various nicotine replacement th

28 arettes might help women who are pregnant to stop smoking, and their safety for use in pregnancy is s

29 ed fat, cholesterol, and calorie intake), to stop smoking, and to increase physical activity.

30 king cessation could help millions of people stop smoking at very low unit costs; however, long-term

31 She had stopped smoking at the age of 40 years after having smok

32 number of life years that would be saved by stopping smoking at various ages, and used an abstinence

33 es provides clear evidence that patients who stop smoking before transplantation experience substanti

34 of smoking), former smokers (persons who had stopped smoking before infarction), quitters (persons wh

35 kers (n=2009), former smokers (those who had stopped smoking before the procedure, n=2259), quitters

36 had never smoked (n = 31,462), patients who stopped smoking before transplantation (n = 10,291) only

37 The infants of 946 women who stopped smoking before week 32 of pregnancy were statist

38 Evidence is limited regarding the effect of stopping smoking before kidney transplantation.

39 In this study, stopping smoking between the first prenatal care visit a

40 ctive of this study was to determine whether stopping smoking between the first prenatal care visit a

41 -cigarettes are commonly used in attempts to stop smoking, but evidence is limited regarding their ef

42 to pregnant women who smoke to help them to stop smoking, but this approach has limited efficacy in

43 risk in individuals who cannot, or will not, stop smoking can be reduced by therapeutic efforts aimed

44 ere acquired from twenty people who recently stopped smoking cigarettes (aged 38 +/- 11 years; 6 fema

45 ho smoked for more than 15 pack-years or who stopped smoking cigarettes less than 25 years ago.

46 d participants with low socioeconomic status stop smoking compared with the information-only website

47 abstinence from smoking at four weeks after stop smoking date, birth weight of baby, cost effectiven

48 pound 400 of financial voucher incentives to stop smoking during pregnancy as an addition to current

49 Ex-smokers who stopped smoking either before or after the onset of the

50 r physical activity, smoking (and failure to stop smoking), excess alcohol consumption, poor diet, ob

51 rimary prevention (getting the population to stop smoking, exercise, lower cholesterol levels, and co

52 Participants who stopped smoking experienced an improvement in FEV(1) in

53 1.38 (95% CI 1.14-1.68) for past smoker who stopped smoking for >= 10 years, 2.61 (95% CI 1.89-3.61)

54 2.61 (95% CI 1.89-3.61) for past smoker who stopped smoking for < 10 years, and 4.01 (95% CI 3.17, 5

55 r cancer surgery, people with cancer who had stopped smoking for at least 4 weeks before surgery had

56 Most people who stopped smoking from both groups relapsed after their ba

57 126 (27%) of 471 participants stopped smoking from the intervention group and 58 (12%)

58 ies: never smoked, quit in the distant past (stopped smoking >2 months prior to time of diagnosis), r

59 ation medications when an individual has not stopped smoking has shown promise, but efficacy has not

60 a history of major depression who attempt to stop smoking have a higher risk of failure than non-depr

61 social ties, groups of interconnected people stop smoking in concert, and smokers are increasingly ma

62 on Asia and why efforts are still needed to stop smoking in Europe.

63 The intervention (ASSIST [A Stop Smoking In Schools Trial] programme) consisted of t

64 A benefit of stopping smoking independent of cumulative dose was sugg

65 Offering pregnant women financial rewards to stop smoking is associated with a more than 2-fold incre

66 Stopping smoking is associated with many important impro

67 ed for more than 15 pack-years (P < .001) or stopped smoking less than 25 years ago (P < .02) compare

68 at occur when daily marijuana users abruptly stop smoking marijuana.

69 After more than 20 years since stopping smoking, men with a mean smoking intensity of m

70 e that patients with MS should be advised to stop smoking once a diagnosis has been made, not only to

71 sulin resistance in humans who are unable to stop smoking or are chronically exposed to secondhand sm

72 creased odds of reporting high motivation to stop smoking (OR(adj) = 1.63, 95%CI 1.06-2.52).

73 ing with current stop smoking services or to stop smoking, or both, during pregnancy.

74 der (P <.001), reported higher motivation to stop smoking (P =.003), and were at a higher stage of ch

75 se executive function in people who recently stopped smoking (p values < 0.05).

76 nd and their associations with motivation to stop smoking, quit attempts, and cessation.

77 lifetime smoking, the cortex of subjects who stopped smoking seems to have partially recovered for ea

78 Data come from 1,826 participants attending Stop Smoking Services (SSS) across England in 2012/13.

79 National Health Service Stop Smoking Services (SSSs) offer help to smokers motiv

80 tion was the offer of usual support from the stop smoking services and the addition of up to pound 40

81 uring pregnancy as an addition to current UK stop smoking services is highly effective.

82 voucher incentives for engaging with current stop smoking services or to stop smoking, or both, durin

83 8 to 4 April 2020, of 4032 women screened by stop smoking services, 944 people were randomly assigned

84 ess, generalisability documenting formats of stop smoking services, and acceptability to pregnant wom

85 r expected date of delivery, engagement with stop smoking services, biochemically validated abstinenc

86 the control group were offered the standard stop smoking services, which includes the offer of couns

87 National Health Service stop-smoking services to either nicotine-replacement pro

88 gnancy, years of smoking, whether the mother stopped smoking, smoking marijuana, passive exposure to

89 eived a counselling call were more likely to stop smoking than those who did not (246 [38%] vs 189 [2

90 If parents are unable or unwilling to stop smoking, they should instigate smoke-free homes.

91 If they stopped smoking, they could reduce their risk of tobacco

92 Smokers should be advised to stop smoking to limit type 2 diabetes and CAD risk.

93 Stop smoking tobacco.

94 program (SI); one-third were advised only to stop smoking (UC).

95 tiate abstinence among smokers who failed to stop smoking with nicotine patch therapy.

96 In persons who stopped smoking with 7 weeks of bupropion treatment, sus

97 end of nicotine patch therapy, 3.1% and 0.0% stopped smoking with bupropion or placebo, respectively

98 not reduce relapse to smoking in smokers who stopped smoking with nicotine patch therapy.

99 s and 12.9% for >5 years) than those who had stopped smoking within the year of their cancer diagnosi